MSFT vs PFE: Which Is the Better Buy?
Side-by-side comparison of Microsoft Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Microsoft Corporation · Technology
$372.20
+32.4% upside to fair value
High Conviction
Grade A
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
MSFT has more upside to fair value
(+32.4%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MSFT |
PFE |
| Current Price |
$372.20 |
$26.91 |
| Fair Value Estimate |
$493.00 |
$35.00 |
| Upside to Fair Value |
+32.4%
|
+30.1%
|
| Market Cap |
$2,763.6B |
$153.0B |
| Forward P/E |
22.0x
|
9.5x
|
| EV / EBITDA |
17.5x
|
13.8x
|
| Price / Sales |
9.1x
|
2.4x
|
| Price / FCF |
35.8x
|
16.8x
|
| Revenue Growth YoY |
+14.9%
|
-1.6%
|
| Gross Margin |
68.8%
|
70.3%
|
| Operating Margin |
45.6%
|
24.7%
|
| Return on Equity |
29.6%
|
9.0%
|
| Dividend Yield |
0.94% |
6.4% |
| FCF Yield |
2.8%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Microsoft is the world's largest software company, operating a three-pillar empire across cloud (Azure), productivity (Office 365/Teams), and personal computing (Windows/Xbox). Azure is the second-largest cloud platform globally with 24% market share and growing at 38-39% in constant currency, while Microsoft Cloud revenue crossed $168.9B in FY2025. The stock has dropped 33% from its highs to $37…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
MSFT |
PFE |
| Zone Low |
$370.00 |
$25.00 |
| Zone High |
$419.00 |
$29.00 |
| In Buy Zone? |
Yes
|
Yes
|